摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-乙酰基-S-苯基-L-甲基半胱氨酸酉酯 | 77549-14-5

中文名称
N-乙酰基-S-苯基-L-甲基半胱氨酸酉酯
中文别名
N-乙酰基-s-苄基-l-半胱氨酸甲酯
英文名称
(+)-2-acetamido-3-benzylthiopropanoic acid methyl ester
英文别名
(+)-N-acetyl-S-benzyl-L-cysteine methyl ester;Ac-L-Cys(Bzl)-OMe;N-acetyl-S-benzyl-L-cysteine methyl ester;N-Acetyl-S-benzyl-L-cystein-methylester;N-Acetyl-S-benzyl-L-cysteine methyl ester;methyl (2R)-2-acetamido-3-benzylsulfanylpropanoate
N-乙酰基-S-苯基-L-甲基半胱氨酸酉酯化学式
CAS
77549-14-5
化学式
C13H17NO3S
mdl
MFCD00066899
分子量
267.349
InChiKey
NELLUUAGFXJBKY-LBPRGKRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    67-73 °C
  • 密度:
    1.2230 (rough estimate)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.384
  • 拓扑面积:
    80.7
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2930909090

SDS

SDS:479e22cf5dce088f91221c015095dcb6
查看
Name: N-Acetyl-S-benzyl-L-cysteine methyl ester Material Safety Data Sheet
Synonym:
CAS: 77549-14-5
Section 1 - Chemical Product MSDS Name:N-Acetyl-S-benzyl-L-cysteine methyl ester Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
77549-14-5 N-Acetyl-S-benzyl-L-cysteine methyl es 100.0 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.)

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 77549-14-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: White - Fine Crystalline Powder
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 67-73 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H17NO3S
Molecular Weight: 267.33

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 77549-14-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Acetyl-S-benzyl-L-cysteine methyl ester - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 77549-14-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 77549-14-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 77549-14-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-乙酰基-S-苯基-L-甲基半胱氨酸酉酯间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 以87%的产率得到(R)-2-Acetylamino-3-phenylmethanesulfinyl-propionic acid methyl ester
    参考文献:
    名称:
    Diastereoselective oxidation of mercapturates to mercapturate sulfoxides
    摘要:
    An efficient and highly diastereoselective synthesis of mercapturate sulfoxides 2 based on the substrate contorolled asymmetric S-oxidation has been accomplished. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0960-894x(96)00157-6
  • 作为产物:
    描述:
    参考文献:
    名称:
    Templates for intramolecular O,N-acyl transfer via cyclic intermediates derived from mercury derivatives of L-cysteine: progress toward a mercury-based thiol capture strategy
    摘要:
    DOI:
    10.1021/jo00277a022
点击查看最新优质反应信息

文献信息

  • Substituted pyrazoles as p38 kinase inhibitors
    申请人:Naraian S. Ashok
    公开号:US20070078146A1
    公开(公告)日:2007-04-05
    A class of pyrazole derivatives is described for use in treating p38 kinase medicated disorders. Compounds of particular interest are defined by Formula IA wherein R 1 , R 2 , R 3 and R 4 are as described in the specification.
    描述了一类吡唑衍生物,用于治疗p38激酶介导的疾病。特别感兴趣的化合物由公式IA定义,其中R1、R2、R3和R4如规范中所述。
  • Regioselectivity of ring-opening reactions of optically active N-acetyl-2-methoxycarbonylaziridine
    作者:Maria Bucciarelli、Arrigo Forni、Irene Moretti、Fabio Prati、Giovanni Torre
    DOI:10.1016/0957-4166(95)00270-y
    日期:1995.8
    (S)-(-)-N-acetyl-2-methoxycarbonylaziridine 1 undergoes easy ring-opening by Bronsted acids or nucleophiles in the presence of a Lewis acid catalyst. The regioselectivity is not always exclusive, affording optically active alpha- and beta-aminoacids.
  • The α-Chymotrypsin-catalyzed Hydrolysis of Acetyl-, Chloroacetyl- and Benzoyl-L-valine Methyl Ester<sup>1</sup>
    作者:Thomas H. Applewhite、Hal Waite、Carl Niemann
    DOI:10.1021/ja01539a047
    日期:1958.3
  • Highly enantioselective amide ligation by prior thiol capture
    作者:D.S. Kemp、David R. Buckler
    DOI:10.1016/0040-4039(91)80674-u
    日期:1991.6
    The mixed disulfides from (R,S)-1-(Cbz-L-alanyloxy)-9-mercapto-phenoxathiin-10-sulfoxide and H-L-Cys-OMe undergo O,N-acyl transfer in DMSO at 23-degrees-C with rate constants of 7.0 h-1 and 0.048 h-1, and a rate ratio of 146; EM values of 0.2 M and 0.0015 M.
  • Peptide synthesis by prior thiol capture. 2. Design of templates for intramolecular O,N-acyl transfer. 4,6-Disubstituted dibenzofurans as optimal spacing elements
    作者:D. S. Kemp、Nicholas G. Galakatos、Benjamin Bowen、Kenneth Tan
    DOI:10.1021/jo00360a033
    日期:1986.5
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物